Talazoparib for newly diagnosed prostate cancer associated with significant risk reduction of disease progression. Nierengarten MB. Cancer 2023;129:2277.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. Talazoparib for newly diagnosed prostate cancer associated with significant risk reduction of disease progression. Cancer 2023;129:2277.
PMID: 37401897